Alsuma Related Clinical Trials
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period [Completed]
Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX� in Healthy Subjects [Completed]
The Effect of Sumatriptan and Placebo on Cilostazol Induced Headache [Recruiting]
The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache [Recruiting]
Sumatriptan and Naratriptan Pregnancy Registry [Completed]
Sumatriptan as Treatment for Post-traumatic Headache [Recruiting]
Bioequivalence Study of Sumatriptan Succinate Tablets 100 mg in Fed Conditions [Completed]
Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents [Completed]
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache [Recruiting]
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents [Completed]
A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System [Completed]
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan [Completed]
Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without [Completed]
Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026) [Completed]
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) [Completed]
Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine [Completed]
Safety & Efficacy of a Single Dose of Sumatriptan Powder Delivered Intranasally With the Bi-directional Device in Adults With Acute Migraine [Completed]
Efficacy of Sumatriptan With Naprosyn in Migraine With Aura [Recruiting]
Effect of Metoclopramide Versus Sumatriptan for Emergency Department Treatment of Migraine Headache [Completed]
Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine [Completed]
Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache [Completed]
Comparing Naproxen to Sumatriptan for Emergency Headache Patients [Completed]
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine [Completed]
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy [Completed]
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2) [Completed]
A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 1 of 2) [Completed]
Migraine Study in Adolescent Patients [Completed]
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs [Completed]
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks [Completed]
Bioequivalence Study of Sumatriptan 100mg Tablets Under Fed Conditions [Completed]
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data [Completed]
Bioequivalence Study of Sumatriptan 100mg Tablets Under Fasting Conditions [Completed]
Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study [Completed]
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) [Completed]
Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo [Completed]
Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period [Completed]
Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex� Tablets 100 mg [Completed]
Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex� Tablets 100 mg [Completed]
The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine [Completed]
Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex� [Completed]
Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment [Completed]
Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy [Recruiting]
Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults [Completed]
TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1) [Completed]
Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions [Completed]
Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions [Completed]
Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department [Completed]
Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex [Completed]
A Study on the Usability of the Needle-Free Intraject® System in Adult Patients During Acute Migraine Attack [Completed]
TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine [Completed]
A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack [Completed]
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) [Completed]
Treximet (Sumatriptan/Naproxen Sodium), Formerly Known as TREXIMA, for Menstrual Migraine in Women With Dysmenorrhea [Completed]
Drug Use Investigation for IMIGRAN Tablet [Completed]
A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses. [Completed]
Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks [Completed]
Treximet in the Treatment of Chronic Migraine [Completed]
Treximet Trademark (TM) in the Prevention and Modification of Disease Progression in Migraine [Completed]
Ictal and Interictal Inflammatory Markers in Migraine [Completed]
TREXIMET� Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults [Completed]
Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan [Completed]
Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) [Completed]
Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers [Completed]
Dose Ranging Study of a Drug for the Treatment of Acute Migraine [Completed]
Study of NXN 188 for the Treatment of Migraine With Aura [Completed]
Prospective Analgesic Compound Efficacy (PACE) Study [Not yet recruiting]
Pilot Study of VVD-101 for the Treatment of Delayed Alcohol-Induced Headaches [Recruiting]
Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction [Terminated]
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months [Completed]
An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months [Completed]
Safety Tolerability and Pharmacokinetics of ALD403 [Completed]
Open Label Pharmacokinetic-Pharmacogenetic Study on Polymorphisms in the Organic Cation Transporter OCT1 [Recruiting]
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches [Completed]
Treximet Early Intervention Adolescent Migraine [Completed]
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months [Completed]
Functional MRI (fMRI) in CGRP Induced Migraine [Completed]
Drug and Non-Drug Treatment Of Severe Migraine [Completed]
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine [Completed]
Trial of Comprehensive Migraine Intervention [Completed]
Efficacy and Safety of BGG492 in the Treatment of Migraine [Completed]
Study in Subjects With Acute Migraines Headaches. [Terminated]
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches [Completed]
Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance [Completed]
Treximet Migraine Brain Imaging Research Study [Terminated]
Treximet in Acute Migraine Headache: Assessing Cognitive Function [Recruiting]
Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms. [Completed]
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? [Recruiting]
Prophylactic Treatment of Episodic Cluster Headache [Completed]
MRA/fMRI Study of Spontaneous Migraine [Recruiting]
A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache [Recruiting]
Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography [Recruiting]
Aminophylline for Patients With Post-Dural Puncture Headache [Not yet recruiting]
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache [Recruiting]
Cupping and Serkangabin Versus Conventional Migraine Treatment [Completed]
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine [Completed]
|